We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,917 results
  1. Reactive Type II Pneumocyte Hyperplasia Versus Adenocarcinoma

    Reactive type II pneumocyte hyperplasia is a nonspecific reactive proliferation of type II pneumocytes in response to a variety of lung injuries and...
    Chapter 2022
  2. Multifocal micronodular pneumocyte hyperplasia lacking typical clinical features of the tuberous sclerosis complex: a case report and literature review

    Background

    Multifocal micronodular pneumocyte hyperplasia (MMPH) is a rare pulmonary manifestation of the tuberous sclerosis complex (TSC) with...

    Shan Li, Chaojie Wu, ... Ningfei Ji in BMC Pulmonary Medicine
    Article Open access 05 March 2022
  3. Ferroptosis and pyroptosis signatures in critical COVID-19 patients

    Critical COVID-19 patients admitted to the intensive care unit (ICU) frequently suffer from severe multiple organ dysfunction with underlying...

    Cédric Peleman, Samya Van Coillie, ... Tom Vanden Berghe in Cell Death & Differentiation
    Article Open access 15 August 2023
  4. P. aeruginosa type III and type VI secretion systems modulate early response gene expression in type II pneumocytes in vitro

    Background

    Lung airway epithelial cells are part of innate immunity and the frontline of defense against bacterial infections. During infection,...

    Emel Sen-Kilic, Annalisa B. Huckaby, ... Mariette Barbier in BMC Genomics
    Article Open access 04 May 2022
  5. Alveolar macrophage metabolic programming via a C-type lectin receptor protects against lipo-toxicity and cell death

    Alveolar macrophages (AM) hold lung homeostasis intact. In addition to the defense against inhaled pathogens and deleterious inflammation, AM also...

    Michal Scur, Ahmad Bakur Mahmoud, ... Andrew P. Makrigiannis in Nature Communications
    Article Open access 25 November 2022
  6. Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection

    In late 2019 the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus emerged in China and quickly spread into a worldwide pandemic. It...

    Aruni Jha, Douglas Barker, ... Shantha Kodihalli in Scientific Reports
    Article Open access 10 October 2022
  7. H1N1 Influenza in Pregnancy: Yet Another Dreaded Flu

    The maternal immune system is already burdened with providing a supportive molecular environment to the develo** genetically foreign fetus....
    Gayathri Prashant Amonkar, Kusum D. Jashnani in Maternal Mortality - Lessons Learnt from Autopsy
    Chapter 2022
  8. The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019

    Background

    The coronavirus disease 2019 (COVID-19) has induced a worldwide epidemiological event with a high infectivity and mortality. However, the...

    Runzhi Huang, Tong Meng, ... Ruilin Liu in Critical Care
    Article Open access 03 July 2021
  9. The possible effects of α-tocopherol against amiodarone-treated lungs in rats: vimentin detection, lipid peroxidation assay, and histological and ultrastructural evaluations

    The purpose of this study was to learn more about the pathogenesis of amiodarone (AD) on alveoli and also the possible preventive effect of...

    Mohamed Samir Ahmed Zaki, Attalla F. El-kott, ... Eman M. Abd-Ella in Environmental Science and Pollution Research
    Article 02 April 2022
  10. Ultrastructural study confirms the formation of single and heterotypic syncytial cells in bronchoalveolar fluids of COVID-19 patients

    Background

    SARS-CoV-2 was reported to induce cell fusions to form multinuclear syncytia that might facilitate viral replication, dissemination, immune...

    Shikha Chaudhary, Ravi P. Yadav, ... Subhash Chandra Yadav in Virology Journal
    Article Open access 19 May 2023
  11. COVID-19 autopsies of Istanbul

    Background/aims

    The aim of this study is to share autopsy findings of COVID-19-positive cases and autopsy algorithms for safely handling of suspicious...

    Murat Nihat Arslan, Yalçın Büyük, ... Arzu Akçay in Irish Journal of Medical Science (1971 -)
    Article 23 March 2021
  12. Autopsy findings of pediatric COVID-19: a systematic review

    Background

    Little is known how COVID-19 is affecting children. Autopsies help gain an understanding of the pathophysiology of new and develo**...

    Gilbert Sterling Octavius, Jeremiah Hilkiah Wijaya, ... Andry Juliansen in Egyptian Journal of Forensic Sciences
    Article Open access 14 July 2022
  13. COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells

    The SARS-CoV-2 virus ACE-2 receptor utilization for cellular entry and the defined ACE-2 receptor role in cardiovascular medicine hinted at...

    Sami Giryes, Nicola Luigi Bragazzi, ... Dennis McGonagle in Seminars in Immunopathology
    Article Open access 12 April 2022
  14. Mechanics of Lung Development

    We summarize how skeletal muscle and lung developmental biology fields have been bridged to benefit from mouse genetic engineering technologies and...
    Mark Baguma-Nibasheka, Boris Kablar in Roles of Skeletal Muscle in Organ Development
    Chapter 2023
  15. MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge

    Numerous vaccine candidates against SARS-CoV-2, the causative agent of the COVID-19 pandemic, are under development. The majority of vaccine...

    Clement A. Meseda, Charles B. Stauft, ... Jerry P. Weir in npj Vaccines
    Article Open access 03 December 2021
  16. Potential protective effect of 3,3′-methylenebis(1-ethyl-4-hydroxyquinolin-2(1H)-one) against bleomycin-induced lung injury in male albino rat via modulation of Nrf2 pathway: biochemical, histological, and immunohistochemical study

    Acute lung injury is a serious condition accounting for the majority of acute respiratory failure. Bleomycin (BLM) is an antibiotic that was first...

    Sara Mohamed Naguib Abdel Hafez, Entesar Ali Saber, ... Manar Fouli Gaber Ibrahim in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 08 December 2022
  17. Combination of losartan with pirfenidone: a protective anti-fibrotic against pulmonary fibrosis induced by bleomycin in rats

    Pirfenidone (PFD), one acceptable medication for treating idiopathic pulmonary fibrosis (IPF), is not well tolerated by patients at full doses....

    Arian Amirkhosravi, Maryamossadat Mirtajaddini Goki, ... Mehrnaz Mehrabani in Scientific Reports
    Article Open access 16 April 2024
  18. Quercetin ameliorates acute lung injury in a rat model of hepatopulmonary syndrome

    Background

    Common bile duct ligation (BDL) is a rat experimental model to induce biliary cirrhosis. Lung fibrosis and pulmonary vascular angiogenesis...

    Noha Abdel-Aziz Nassef, Manal S. Abd-El Hamid, ... Asmaa Ibrahim Ahmed in BMC Complementary Medicine and Therapies
    Article Open access 03 December 2022
  19. A mammalian lung's immune system minimizes tissue damage by initiating five major sequential phases of defense

    The mammalian lungs encounter several pathogens, but have a sophisticated multi-phase immune defense. Furthermore, several immune responses to...

    Article 04 May 2023
Did you find what you were looking for? Share feedback.